Robert Berman, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 104,155 shares at $36.01 ($3.8M) on 2018-06-08, disclosed to the SEC on 2018-06-12.
Open-market sale of $3.8M BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.01 | 1,671 | $60K | 1.6% |
| 2 | $36.01 | 6,735 | $243K | 6.4% |
| 3 | $35.25 | 1,218 | $43K | 1.1% |
| 4 | $35.25 | 4,409 | $155K | 4.1% |
| 5 | $36.15 | 55,907 | $2.0M | 53.4% |
| 6 | $36.16 | 13,858 |
| $501K |
| 13.2% |
| 7 | $36.65 | 100 | $4K | 0.1% |
| 8 | $37.07 | 2,604 | $97K | 2.6% |
| 9 | $37.07 | 10,647 | $395K | 10.4% |
| 10 | $38.00 | 1,377 | $52K | 1.4% |
| 11 | $38.00 | 5,629 | $214K | 5.7% |
| Total | $36.33 avg | 104,155 | $3.8M | 100% |
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $13.3M | — | Filing → |
| BHVN | BUY | 2019-06-28 | $106K | — | Filing → |